Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Charles River Laboratories International

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 12
Average round size
info
The average size of a deal this fund participated in
$27M
Portfolio companies 8
Rounds per year 0.16
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.33
Exits 1
Key employees Soon

Areas of investment

  • Biotechnology
  • Health Care
  • Therapeutics
  • Life Science
  • Medical
Summary

In 1947 was created Charles River Laboratories International, which is appeared as Corporate Investor. The main office of represented Corporate Investor is situated in the Wilmington. The company was established in North America in United States.

The typical case for the fund is to invest in rounds with 7 participants. Despite the Charles River Laboratories International, startups are often financed by Kurma Partners, Idinvest Partners, Aurinvest. The meaningful sponsors for the fund in investment in the same round are investiere | Verve Capital Partners, Strategic Partners, Norgine Ventures.

Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - France. Among the most successful fund investment fields, there are Biotechnology, Therapeutics. Among the various public portfolio startups of the fund, we may underline PathoQuest

The usual things for fund are deals in the range of 5 - 10 millions dollars. The fund is constantly included in less than 2 deals per year. The top activity for fund was in 2019.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Charles River Laboratories International:
Typical Co-investors
Charles River Laboratories International is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Charles River Laboratories International:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Divinium Capital -
Genesis Microchip California, Santa Clara, United States
Guangzhou Yuanjian Xinchuang Touzi Guanli Hehuo Qiye (Youxian Hehuo) China, Guangdong, Guangzhou
JOT-Berlin Berlin, Berlin, Germany
oprandi & partner management ag -
Squadron Venture Media England, London, United Kingdom
Tata Communications India, Maharashtra, Mumbai
Weishi Culture Media Beijing, Beijing, China
Yukti Securities -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Ability biologics

Biotechnology
Life Science
$12M06 Dec 2023 Quebec, Quebec, Canada

Vernal Biosciences

$20M27 Jun 2023 Burlington, Vermont, United States

iVexSol

Manufacturing
$23M26 Jan 2023 New York, New York, United States

Wheeler Bio

Biotechnology
Life Science
Therapeutics
$31M04 Oct 2022 Oklahoma City, Oklahoma, United States

Vernal Biosciences

$21M02 Jun 2022 Burlington, Vermont, United States

Deciphex

$11M19 May 2022 Dublin, County Dublin, Ireland

PathoQuest

Biotechnology
Health Care
Therapeutics
$17M09 Nov 2021 Paris, Ile-de-France, France

Bit Bio

Biotechnology
Commercial
Health Care
$103M05 Nov 2021 Cambridge, Massachusetts, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Charles River Laboratories International?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 12
Average round size 27M
Rounds per year 0.16
Peak activity year 2022
Lead investments 1
Follow on index 0.33
Exits 1
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Ability biologics

Biotechnology
Life Science
$12M06 Dec 2023 Quebec, Quebec, Canada

Vernal Biosciences

$20M27 Jun 2023 Burlington, Vermont, United States

iVexSol

Manufacturing
$23M26 Jan 2023 New York, New York, United States

Wheeler Bio

Biotechnology
Life Science
Therapeutics
$31M04 Oct 2022 Oklahoma City, Oklahoma, United States

Vernal Biosciences

$21M02 Jun 2022 Burlington, Vermont, United States

Deciphex

$11M19 May 2022 Dublin, County Dublin, Ireland

PathoQuest

Biotechnology
Health Care
Therapeutics
$17M09 Nov 2021 Paris, Ile-de-France, France

Bit Bio

Biotechnology
Commercial
Health Care
$103M05 Nov 2021 Cambridge, Massachusetts, United States
Crunchbase icon

Content report

The following text will be sent to our editors: